Probably not illegal, but leaves a bad taste. I get the surface-level appeal of this guy's narrative (especially his CNBC appearences), but I don't get the idolatry towards him. He's not some sort of people's hero, he's just another rich guy who sometimes has cathartic rants about other rich people in order to get richer.
[1] https://twitter.com/tysonbrody/status/1355967493089669131
Guess what? For years and years and years, everyone thought "Wall Street" was right, because real estate prices kept going up and up and up and up. People who saw what was happening, like Michael Burry, took an absolute thrashing on their short positions for years because the market refused to correct itself, it just kept going up despite the problems becoming increasingly obvious.
That is not obviously different from the Tesla situation. Chamath sounds like he's cheerleading the exact kind of narrative that he criticized Wall Street for not being critical of. And in any case it's not like the history of Tesla ended last week, so absolutist statements of "right" or "wrong" are nonsense.
If GME debacle taught us (again?) anything, it's that markets are moved by narratives. And those raccoons who control the narrative can move the market towards their favour.
Great post on epsilon theory on this https://www.epsilontheory.com/hunger-games/
https://www.cnbc.com/amp/2018/11/02/tesla-says-doj-and-sec-a...
As an investor, you should have a right to be informed of investment risks.
An active/ongoing DOJ investigation (even if routine) seems like something investors would need to be aware of to make an informed investment decision.
https://www.cnbc.com/2021/02/05/chamath-palihapitiya-backed-...
In short, Clover Health is going public via a SPAC, but never disclosed it was under investigation by the DOJ.
> Clover said it decided it did not need to disclose the DOJ inquiries after consultation with its lawyers. The company did not say what the DOJ’s inquiries were about.
SPACs short-cut disclosure requirements, making it easier for companies to go public without the typical scrutiny that comes with the IPO process.